Holen Sie sich die Stockscreener-App
4.25
2.07%
-0.09
Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.95%
0.2437
|
0.2511 | 3.96 | 3.5643 | 0.1636 |
| Operating Expenses |
7.61%
7.2907
|
7.8914 | 9.9909 | 5.9972 | 6.5781 |
| Operating Income/Loss |
7.76%
-7.047
|
-7.6402 | -6.0309 | -2.4329 | -6.4145 |
| Income/Loss From Continuing Operations Before Tax |
7.89%
-6.6383
|
-7.207 | - | 3.5643 | -6.095 |
| Net Income/Loss |
7.89%
-6.6383
|
-7.207 | -5.7085 | -2.1158 | -6.095 |
| Basic Average Shares |
3.59%
23.46
|
22.64 | - | 16.73 | 16.72 |
| Diluted Average Shares |
3.59%
23.46
|
22.64 | - | 16.73 | 16.72 |
| Basic Earnings Per Share |
12.50%
-0.28
|
-0.32 | - | -0.13 | -0.36 |
| Diluted Earnings Per Share |
12.50%
-0.28
|
-0.32 | - | -0.13 | -0.36 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):